N'-(6-Chloropyridin-2-yl)formohydrazide

Catalog No. :
ACTBGV193
CAS No. :
66999-50-6
Molecular Formula :
C6H6ClN3O
Molecular Weight :
171.59

IUPAC Name:N'-(6-chloropyridin-2-yl)formohydrazide

N'-(6-Chloropyridin-2-yl)formohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$97.00Login to see priceInquiryInquiry
5g98%$252.00Login to see priceInquiryInquiry
25g98%$717.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN'-(6-Chloropyridin-2-yl)formohydrazide
IUPAC NameN'-(6-chloropyridin-2-yl)formohydrazide
MDL No.N185928
Molecular FormulaC6H6ClN3O
Molecular Weight171.59
SMILESO=CNNC1=NC(Cl)=CC=C1
InChI KeyWYTWCUFAJMZIPZ-UHFFFAOYSA-N
SynonymN'-(6-Chloropyridin-2-yl)formohydrazide | 66999-50-6 | N-[(6-chloropyridin-2-yl)amino]formamide | (N-Formyl-N'-(6-Chloropyrid-2yl)hydrazine) | NSC289801 | DTXSID60314913 | MFCD11706996 | AKOS006345794 | NSC-289801 | SB86423 | BS-23679 | FT-0685645 | A867353 | J-523137
CAS No.66999-50-6
PubChem CID324433

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTBGV193 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2 In Stock
  4. Then
  5. ACTBGV193 route product structure diagram
    ACTBGV19366999-50-6
Inquiry

2. ACTBGV193 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTBGV193 route product structure diagram
    ACTBGV19366999-50-6
Inquiry

Comments (0)